首页 | 本学科首页   官方微博 | 高级检索  
     


Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use
Authors:Inka Wiegratz,Skadi Stahlberg,Nicole Sä  nger,Ernesta Palombo-Kinne,Evelyn Lange
Affiliation:a Center of Obstetrics and Gynecology, University Hospital of Frankfurt, D-60590 Frankfurt, Germany
b Jenapharm GmbH & Co KG, D-07745 Jena, Germany
Abstract:

Background

The effects of extended regimens of combined oral contraceptives (COC) on lipid parameters are largely unknown. The present study compared the effects of a COC containing 30 mcg ethinyl estradiol and 2 mg dienogest (EE/DNG) in conventional and extended-cycle regimen over 1 year.

Study Design

Lipid parameters were measured in 59 women treated with EE/DNG either conventionally (21+7 days) or in extended-cycle regimen (84+7 days). Blood samples were taken in a control cycle and at 3 and 12 months of treatment.

Results

The mean levels of total cholesterol, HDL cholesterol and HDL2 cholesterol underwent modest to moderate significant increases over time, while the significant increase in triglycerides and VLDL cholesterol was more pronounced with both regimens. LDL cholesterol decreased slightly in both regimen groups, whereas lipoprotein(a) was transiently decreased at 3 months only in the extended-cycle group. The changes reached a steady-state at latest at 3 months, but did not exceed the given normal ranges for any of the parameters. Notably, except for lipoprotein(a), the changes in mean lipid levels were not significantly different in the conventional and the extended-cycle regimen at 3 or 12 months of treatment.

Conclusion

Use of EE/DNG in conventional or extended-cycle regimen resulted in comparable changes of lipid parameters.
Keywords:Oral contraceptives   Extended-cycle regimen   Ethinyl estradiol   Dienogest   Lipid metabolism
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号